CpG-induced IFNgamma Expands TLR4-specific IL-18 Responses in Vivo
Overview
Cell Biology
Authors
Affiliations
Serum IL-18 responses to LPS increase after pretreatment with CpG-containing DNA. Compared to saline-pretreated controls, mice pretreated with CpG for two days produced 20-fold more serum IL-18 when challenged with lipopolysaccharide (LPS). In contrast, IFNgamma-deficiency or anti-IFNgamma pretreatment reduced CpG-expanded IL-18 responses to LPS by 67 and 83%, respectively. Mice pretreated with either IFNgamma or CpG comparably increased LPS-inducible serum IL-18 responses. LPS, compared to challenge with other TLR agonists, was best able to trigger high serum IL-18 levels in CpG-pretreated mice and this response was TLR4-dependent. CpG, compared to pretreatment with other TLR agonists, optimally expanded LPS-induced IL-18 responses that correlated with higher levels of circulating IFNgamma levels prior to LPS challenge. High-level serum IL-18 responses were caspase-1-dependent and P2X7 receptor-independent. We conclude that CpG promotes high-level IL-18 synthesis by an IFNgamma-dependent and IFNgamma-sufficient mechanism in vivo that is optimally triggered by LPS.
Protective role of Cecropin AD against LPS-induced intestinal mucosal injury in chickens.
Zhi Y, Li T, Li Y, Zhang T, Du M, Zhang Q Front Immunol. 2024; 14:1290182.
PMID: 38162646 PMC: 10757607. DOI: 10.3389/fimmu.2023.1290182.
RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma.
Kahm Y, Kim I, Kim R Int J Mol Sci. 2023; 24(7).
PMID: 37047826 PMC: 10095367. DOI: 10.3390/ijms24076855.
Cui W, Joshi N, Liu Y, Meng H, Kleinstein S, Kaech S J Immunol. 2014; 192(9):4221-32.
PMID: 24659688 PMC: 4071140. DOI: 10.4049/jimmunol.1302569.
IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice.
Yu Q, Vazquez R, Khojeini E, Patel C, Venkataramani R, Larson D Am J Physiol Heart Circ Physiol. 2009; 297(1):H76-85.
PMID: 19429811 PMC: 2711747. DOI: 10.1152/ajpheart.01285.2008.